Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Beyer, J."'
Autor:
Bührer E; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., D'Haese D; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Daugaard G; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Albany C; Horizon Oncology Research, 1345 Unity PI Ste 345, Lafayette, IN, United States of America., Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation., Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Stahl O; Department of Oncology, Skåne University Hospital, Lund, Sweden., Gietema JA; University Medical Centre Groningen, Groningen, the Netherlands., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG), Italy., Cafferty FH; Medical Research Council Clinical Trials Unit, University College London (UCL), London, United Kingdom; Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Tandstad T; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway., Huddart RA; Institute of Cancer Research, Sutton, United Kingdom., Necchi A; Vita-Salute San Raffaele University, Milan, Italy; Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Garcia-Del-Muro X; Catalan Institute of Oncology, IDIBELL Institute of Research, University of Barcelona, Barcelona, Spain., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany., Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia; Cancer Research Institute, Biomedical Center, Slovak Academy of Sciences, Bratislava, Slovakia., Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada., Grimison P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia., Feldman DR; Memorial Sloan Kettering Cancer Centre, New York, NY, United States of America; Weill Medical College of Cornell University, New York, NY, United States of America., Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany., Bokemeyer C; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Negaard H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fankhauser C; University of Zurich, Zurich, Switzerland., Shamash J; St Bartholomew's Hospital, London, United Kingdom., Vaughn DJ; University of Pennsylvania, Philadelphia, PA, United States of America., Sternberg CN; Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany; Department of Urology, Medical University Vienna, Austria., Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland; Universita della Svizzera Italiana (USI), Lugano, Switzerland., Beyer J; University Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland. Electronic address: joerg.beyer@insel.ch.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 114042. Date of Electronic Publication: 2024 Mar 30.
Autor:
Lauritsen J; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark., Sauvé N; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Tryakin A; Department of Chemotherapy, N.N.Blokhin Russian Cancer Research Center, Moscow, Russia., Jiang DM; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Huddart R; Institute of Cancer Research and Royal Marsden Hospital, Downs Road, Sutton, Surrey, UK., Heng DYC; Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Terbuch A; Division of Oncology, Medical University of Graz, Graz, Austria., Winquist E; Department of Oncology, University of Western Ontario and London Health Sciences Centre, London, ON, Canada., Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia., Hentrich M; Department of Hematology/Oncology, Red Cross Hospital, Munich, Germany., Fankhauser CD; University of Zurich, Zurich, Switzerland.; University of Lucerne, Lucerne, Switzerland., Shamash J; Department of Oncology, St Bartholomew's Hospital, London, UK., Del Muro XG; Department of Medical Oncology, Catalan Institute of Oncology, Barcelona, Spain., Vaughn D; Division of Hematology/Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA., Heidenreich A; Department of Urology, Uro-Oncology, Robot Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany., Sternberg CN; Englander Institute for Precision Medicine, Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York-Presbyterian, New York, NY, USA., Sweeney C; Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA., Necchi A; Vita-Salute San Raffaele University, Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy., Bokemeyer C; Department of Oncology, Hematology and BMT with section Pneumonology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Bandak M; Department of Consulting and Research, International Drug Development Institute, Louvain-la-Neuve, Belgium., Jandari A; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Collette L; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium., Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.; University of Southern Switzerland, Lugano, Switzerland., Beyer J; Department of Medical Onccology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. joerg.beyer@insel.ch., Daugaard G; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Nov; Vol. 129 (11), pp. 1759-1765. Date of Electronic Publication: 2023 Sep 30.
Autor:
Speicher P; Department of Medical Oncology and Hematology, Hospital of Thun, 3600, Bern, Switzerland.; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland., Fankhauser CD; Department of Urology, Lucerne Cantonal Hospital, 6000, Luzern, Switzerland., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, 8006, Zurich, Switzerland., Ardizzone D; Faculty of Medicine, University of Zurich, 8006, Zurich, Switzerland., Helnwein S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland., Hoch D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, Zurich, Switzerland., Beyer J; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland. joerg.beyer@insel.ch., Akhoundova D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, 3010, Bern, Switzerland.; Department for Biomedical Research, University of Bern, 3008, Bern, Switzerland.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Sep 15; Vol. 23 (1), pp. 870. Date of Electronic Publication: 2023 Sep 15.
Autor:
Notarfrancesco M; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Ardizzone D; Department of Urology, University Hospital Zurich, Zurich, Switzerland., Helnwein S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Hoch D; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, Zurich, Switzerland., Thalmann G; Department of Urology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Beyer J; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
Publikováno v:
Swiss medical weekly [Swiss Med Wkly] 2023 Apr 10; Vol. 153, pp. 40053. Date of Electronic Publication: 2023 Apr 10.
Autor:
Grogg JB; Department of Urology, University of Zurich, Zurich, Switzerland., Dursun ZH; Department of Urology, University of Zurich, Zurich, Switzerland., Beyer J; Department of Oncology, Inselspital Bern, University of Bern, Bern, Switzerland., Eberli D; Department of Urology, University of Zurich, Zurich, Switzerland., Poyet C; Department of Urology, University of Zurich, Zurich, Switzerland., Hermanns T; Department of Urology, University of Zurich, Zurich, Switzerland., Fankhauser CD; Department of Urology, University of Zurich, Zurich, Switzerland. cdfankhauser@gmail.com.; Department of Urology, Cantonal Hospital of Lucerne, Lucerne, Switzerland. cdfankhauser@gmail.com.
Publikováno v:
World journal of urology [World J Urol] 2022 Sep; Vol. 40 (9), pp. 2293-2303. Date of Electronic Publication: 2022 Jul 12.
Autor:
Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, Portugal., Rodrigues Â; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, Portugal., Henrique R; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Cancer Biology and Epigenetics Group, IPO Porto Research Center (GEBC CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Rua Jorge Viterbo Ferreira 228, Porto, Portugal., Christiansen A; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zurich, Switzerland., Beyer J; Universitätsklinik für Medizinische Onkologie, Inselspital, Universitätsklinik der Universität Bern, Bern University, Bern, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Rämistrasse 71, Zurich, Switzerland., Bode PK; Department of Pathology and Molecular Pathology, University Hospital Zurich, Schmelzbergstrasse 12, Zurich, Switzerland.
Publikováno v:
Histopathology [Histopathology] 2022 Jul; Vol. 81 (1), pp. 84-98. Date of Electronic Publication: 2022 May 05.
Autor:
Fankhauser CD; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. cdfankhauser@gmail.com., Christiansen AJ; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Rothermundt C; Department of Oncology, Kantonsspital, St. Gallen, Switzerland., Cathomas R; Department of Oncology, Kantonsspital Chur, Chur, Switzerland., Wettstein MS; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Grossmann NC; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Grogg JB; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Templeton AJ; Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland., Hirschi-Blickenstorfer A; Onkozentrum Hirslanden, Klinik Hirslanden, Zürich, Switzerland., Lorch A; Department of Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Gillessen S; Department of Oncology, Kantonsspital, St. Gallen, Switzerland.; EOC Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Universita della Svizzera Italiana, Lugano, Switzerland.; University of Bern, Bern, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Beyer J; Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland., Hermanns T; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 May; Vol. 126 (8), pp. 1140-1144. Date of Electronic Publication: 2021 Dec 15.
Autor:
Beyer J; Universitätsklinik für Medizinische Onkologie, Inselspital, Universitätsklinik der Universität Bern, Universität Bern, Switzerland., Berthold D; Département d'oncologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Bode PK; Institut für Pathologie und Molekularpathologie, Universitätsspital Zurich, Switzerland., Cathomas R; Onkologie/Hämatologie, Kantonsspital Graubünden, Chur, Switzerland., Fankhauser CD; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK., Fischer S; Kantonsspital St. Gallen, Klinik für Onkologie und Hämatologie, St. Gallen, Switzerland., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland., Gross T; Universitätsklinik für Urologie, Inselspital, Universitätsklinik der Universität Bern, Universität Bern, Switzerland., Hermanns T; Universitätsspital Zürich, Klinik für Urologie, Universität Zürich, Zürich, Switzerland., Honecker F; Tumor- und Brustzentrum, ZeTuP, St. Gallen, Switzerland., Lorch A; Klinik für medizinische Onkologie und Hämatologie, Universitätsspital Zürich, Switzerland., Omlin A; Kantonsspital St. Gallen, Klinik für Onkologie und Hämatologie, St. Gallen, Switzerland., Papachristofilou A; Klinik für Strahlentherapie und Radioonkologie, Universitätsspital Basel, Basel, Switzerland., Roth B; Service d'urologie, Centre hospitalier universitaire vaudois, University of Lausanne, Switzerland., Rothermundt C; Kantonsspital St. Gallen, Klinik für Onkologie und Hämatologie, St. Gallen, Switzerland., Seiler R; Universitätsklinik für Urologie, Inselspital, Universitätsklinik der Universität Bern, Universität Bern, Switzerland., Spahn M; Urologie Boxler und Spahn / Lindenhofspital Bern; Klinik für Urologie, Universitätsklinik Essen, Germany., Stenner F; Universitätsklinik Basel, Abteilung für Onkologie, Basel, Switzerland., Bührer E; Universitätsklinik für Medizinische Onkologie, Inselspital, Universitätsklinik der Universität Bern, Universität Bern, Switzerland.
Publikováno v:
Swiss medical weekly [Swiss Med Wkly] 2021 Aug 23; Vol. 151 (33-34). Date of Electronic Publication: 2021 Aug 23.
Autor:
Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland.; Universita della Svizzera Italiana, Lugano, Switzerland.; University of Manchester, Manchester, United Kingdom., Sauvé N; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Daugaard G; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., de Wit R; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Albany C; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN., Tryakin A; N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation.; Research Institute of Oncology at Bashkir State Medical University, Ufa, Russian Federation., Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Stahl O; Department of Oncology, Skåne University Hospital, Lund, Sweden., Gietema JA; University Medical Center Groningen, Groningen, the Netherlands., De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy and the Italian Germ Cell Cancer Group (IGG)., Cafferty FH; Medical Research Council Clinical Trials Unit, University College London (UCL), London, United Kingdom., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Tandstad T; The Cancer Clinic, St Olavs University Hospital and Department of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway., Huddart RA; Institute of Cancer Research, Sutton, United Kingdom., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Current Affiliation: Vita-Salute San Raffaele University and IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy., Sweeney CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Garcia-Del-Muro X; Catalan Institute of Oncology, IDIBELL Institute of Research, University of Barcelona, Barcelona, Spain., Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; Department of Urology, University Hospital Dusseldorf, Dusseldorf, Germany., Chovanec M; 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia., Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, Ontario, Canada., Grimison P; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Sydney, Australia., Feldman DR; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Medical College of Cornell University, New York, NY., Terbuch A; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria., Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany., Bokemeyer C; Department of Oncology, Hematology and BMT with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Negaard H; Department of Oncology, Oslo University Hospital, Oslo, Norway., Fankhauser C; University of Zurich, Zurich, Switzerland., Shamash J; St Bartholomew's Hospital, London, United Kingdom., Vaughn DJ; University of Pennsylvania, Philadelphia, PA., Sternberg CN; Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. Current Affiliation: Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, NY., Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany., Beyer J; University Department of Medical Oncology, Inselspital, University Hospital, University of Bern, Bern, Switzerland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 10; Vol. 39 (14), pp. 1563-1574. Date of Electronic Publication: 2021 Apr 06.
Autor:
Fischer S; Cantonal Hospital St Gallen, Department of Medical Oncology and Hematology, St. Gallen, Switzerland.; Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, and The Christie NHS Foundation Trust, Manchester, United Kingdom., Tandstad T; The Cancer Clinic, St Olavs University Hospital, Trondheim, Norway.; SWENOTECA, Trondheim, Norway., Cohn-Cedermark G; SWENOTECA, Trondheim, Norway.; Department of Oncology-Pathology, Karolinska Institute, Stockholm, and Department of Oncology, Karolinska University Hospital, Stockholm, Sweden., Thibault C; Department of Medical Oncology, Hôpital Européen Georges Pompidou, Paris, France., Vincenzi B; University Campus Bio-Medico, Rome, Italy., Klingbiel D; F Hoffmann-La Roche Ltd, Basel, Switzerland., Albany C; Indiana University School of Medicine, Melvin and Bren Simon Cancer Center, Indianapolis, IN., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Terbuch A; Abteilung für Onkologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz, Graz, Austria., Lorch A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Aparicio J; Hospital Universitari I Politècnic La Fe, Valencia, Spain, Spanish Germ Cell Cancer Group., Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany., Hentrich M; Department of Hematology and Oncology, Red Cross Hospital, University of Munich, Munich, Germany., Wheater M; Medical Oncology, University Hospital Southampton, Southampton, United Kingdom., Langberg CW; SWENOTECA, Trondheim, Norway.; The Cancer Centre, Oslo University Hospital, Oslo, Norway., Ståhl O; SWENOTECA, Trondheim, Norway.; Department of Oncology, Skane University Hospital, Lund, Sweden., Fankhauser CD; University of Zürich, Zürich, Switzerland., Hamid AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Koutsoukos K; National & Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece., Shamash J; St Bartholomew's Hospital, London, United Kingdom., White J; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Bokemeyer C; Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Beyer J; University Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Gillessen S; Cantonal Hospital St Gallen, Department of Medical Oncology and Hematology, St. Gallen, Switzerland.; Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, and The Christie NHS Foundation Trust, Manchester, United Kingdom.; University of Bern, Bern, Switzerland.; Oncology Institute of Southern Switzerland, Bellinzona and Universita della Svizzera Italiana, Lugano, Switzerland.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 20; Vol. 38 (12), pp. 1322-1331. Date of Electronic Publication: 2019 Dec 26.